Michael Rivner, MD
Clinical Neurophysiology · Macon, GANPI 1669582649
Payments from drug & device makers
Across 602 payments — averaging $1748.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB SA$388K
- Argenx US, Inc.$197K
- AstraZeneca$144K
- Janssen Research & Development, LLC$78K
- Orion Corporation$70K
- UCB, Inc.$67K
- plus $110K from 31 others
Across 5 payments — averaging $775.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB, Inc.$3K
- AstraZeneca$758
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB SA | 54 | $387,587 |
| Argenx US, Inc. | 102 | $196,648 |
| AstraZeneca(2 entities) | 150 | $143,806 |
| Janssen Research & Development, LLC | 10 | $77,690 |
| Orion Corporation | 13 | $69,862 |
| UCB, Inc. | 77 | $67,408 |
| UCB GmbH | 1 | $36,220 |
| AbbVie(2 entities) | 98 | $18,665 |
| Johnson & Johnson | 20 | $18,266 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $13,525 |
| Amgen(2 entities) | 10 | $12,753 |
| Catalyst Pharmaceuticals, Inc. | 3 | $4,378 |
| Grifols Therapeutics LLC | 1 | $2,606 |
| UCB Biosciences Inc. | 1 | $2,364 |
| Pfizer | 7 | $149 |
| Tanabe Pharma America, Inc. | 6 | $109 |
| Sunovion Pharmaceuticals Inc. | 14 | $103 |
| Ventec Life Systems, Inc. | 1 | $87 |
| Teva Pharmaceuticals USA, Inc. | 4 | $81 |
| Grifols USA, LLC | 3 | $55 |
| SK Life Science, Inc. | 2 | $53 |
| Revance Therapeutics, Inc. | 2 | $45 |
| Jazz Pharmaceuticals Inc. | 2 | $44 |
| Amylyx Pharmaceuticals, Inc. | 1 | $32 |
| Novartis | 2 | $29 |
| Lundbeck LLC | 1 | $27 |
| Averitas Pharma Inc. | 1 | $27 |
| Greenwich Biosciences, Inc. | 1 | $23 |
| Hospira, Inc. | 1 | $22 |
| EDW Pharma, Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
| GE HealthCare | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Advanced Respiratory, Inc | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
| Natus Medical Incorporated | 1 | $11 |
How this compares
Too few clinical neurophysiology providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical neurophysiology in Macon
- William RocheMacon$474
- Kashyap PatelStatesboro$199K
- Ashish KabirDalton$83K
- Joseph HormesMarietta$4K
- Sachin KedarAtlanta$3K
- Gregory EsperAtlanta$3K
- Sara Ann Schleicher-DilksGainesville$14
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.